Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Brazil / NCT06108674
Recruiting Not applicable

Telepharmacy on Patients With Arterial Hypertension

NCT06108674 · tracked via the Priya Life Science Brazil tracker
Sponsor
Federal University of Bahia
Phase
Not applicable
Started
2023-11-01
Last updated
2025-08-12

Condition(s) studied

Hypertension

Investigational drug(s) / intervention(s)

Pharmaceutical care via telepharmacy and usual carePharmaceutical care in-person and usual care

Pharmaceutical care via telepharmacy and usual care: Pharmacotherapeutic monitoring via telephone consultation

Pharmaceutical care in-person and usual care: Face-to-face pharmacotherapeutic monitoring

Study summary

The goal of this clinical trial is to compare the effectiveness of a pharmaceutical care protocol via teleconsultation in the management of uncontrolled hypertension with pharmaceutical care carried out in elderly patients assisted in primary health care. The main questions it aims to answer are:

1. How effective is a pharmaceutical care protocol via teleconsultation on the clinical outcomes of elderly people with uncontrolled hypertension, when compared to in-person pharmaceutical care?
2. How effective is a pharmaceutical care protocol via teleconsultation in adherence to the treatment of elderly people with hypertension, when compared to in-person pharmaceutical care?

Participants will undergo four visits. Two visits will be for the application of instruments and measurement of clinical parameters to be carried out at the beginning and end of follow-up (visits 1 and 4). These will be carried out in a pharmacist's office at the pharmacy by previously trained pharmacists and pharmacy students. Visits 2 and 3 will be pharmaceutical consultations to be carried out in person and/or via telepharmacy.

Researchers will compare pharmaceutical care via telepharmacy with in-person pharmaceutical care to see how effective these services are in controlling blood pressure in elderly patients with uncontrolled blood pressure.

Eligibility

Sex
ALL
Min age
60 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Elderly patients admitted to the service with a diagnosis of systemic arterial hypertension made by a physician based on a patient report, report or medical prescription. * Patients who present uncontrolled blood pressure at the time of assessment based on the average of three measurements using a standardized protocol at the pharmacy will be included; * Patients must have a cell phone and know how to use it; * Patient not have previously received pharmaceutical care. Exclusion Criteria: * Elderly people who are unable to use their cell phones due to cognitive impairments (Mini Mental State Examination (MMSE). * Elderly person considered unable of using a telephone (Instrumental Activities of Daily Living) * Elderly with controlled blood pressure according to home monitoring.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Farmácia Escola da UFBA, campus Anísio Teixeira Vitória da Conquista Estado de Bahia Recruiting

More Federal University of Bahia trials in Brazil

Effects of GPR on Non-Specific Chronic Low Back Pain Recruiting
Transauricular Vagus Nerve Stimulation Frequencies for Postoperative Pain Recruiting
Parents in Action: An Online Intervention Aimed at Parents' Well-being Recruiting

Other trials for the same condition

iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease Recruiting
Inorganic Nitrate Supplementation in Chronic Hypertensive Pregnancies Recruiting
Cf-PWV and TyG Index Study Starting soon
Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06108674 on ClinicalTrials.gov ↗ ← All trials in Brazil